InvestorsHub Logo
Followers 0
Posts 294
Boards Moderated 0
Alias Born 09/15/2016

Re: A deleted message

Saturday, 06/20/2020 7:56:24 AM

Saturday, June 20, 2020 7:56:24 AM

Post# of 3647
It must be painful for Calvin Wallen, Grant Gordon, and the rest of the non-existent team at Venturis Therapeutics (formerly Cardiovascular Biotherapeutics) to see their lunch being eaten in broad daylight by the former CEO. I have no skin in the game for whatever Dan Montano is doing, but at least he's doing it unlike this pathetic group. So much for all the lies and broken promises from this uneducated bunch of losers that call themselves Venturis Therapeutics leadership. A less credible bunch would be impossible to find. I guess having only a high school diploma actually means something in the real world. Yes, this company is led by someone who only has a high school diploma--Calvin Wallen III. And Grant Gordon doesn't have even that! At least both share in common that they're dropout losers, so no wonder they relate so well to one another--until of course Wallen laughs at Gordon behind his back and ridicules him constantly as there have been numerous reports through the grapevine.

The countdown to the Venturis Therapeutics bankruptcy filing continues. With Venturis/CVBT losing a 7-figure judgement to Dan Montano (I still haven't heard an exact figure, but I'm sure we will soon), the only thing I'm unclear on is whether the coming bankruptcy will be voluntary or involuntary. Let's just hope that the "alleged" $150 million funding that is "rumored" on this message board (and certainly not based in any reality) takes place soon hahahaha, so Venturis/CVBT can pay off Montano and its other creditors before they likely take the kind of actions that companies don't recovery from.

Here's the current state of things:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716827

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.